Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Mayo Clinic Laboratories Mayo Clinic United States | 23 | 30 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics United States | 345 | 159 |
|
Invitae Hereditary Cerebral Small Vessel Disease Panel Invitae United States | 24 | 10 |
|
Cerebral Small Vessel Disease Panel PreventionGenetics United States | 13 | 10 |
|
Wole Exome Sequencing for Hemiplegic Migraine, Epilepsy, Ataxia, CADASIL/Small Vessel Disease Genomics Research Centre Queensland University of Technology Australia | 12 | 4 |
|
Leukodystrophy and Leukoencephalopathy, Adult Onset Panel PreventionGenetics United States | 46 | 37 |
|
Invitae Mendelian Disorders with Psychiatric Symptoms Panel Invitae United States | 247 | 163 |
|
Cerebral small vessel disease NGS panel HNL Genomics Connective Tissue Gene Tests United States | 8 | 7 |
|
HNL Genomics Connective Tissue Gene Tests United States | 3 | 2 |
|
Cerebral small vessel disease Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 8 | 7 |
|
HNL Genomics Connective Tissue Gene Tests United States | 3 | 2 |
|
CADASIL Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 3 | 2 |
|
Cerebral small vessel disease Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 8 | 7 |
|
Leukodystrophy and Leukoencephalopathy Panel PreventionGenetics United States | 201 | 211 |
|
CADASIL2 and CARASIL via the HTRA1 Gene PreventionGenetics United States | 2 | 1 |
|
PreventionGenetics United States | 3 | 2 |
|
Genetic Services Laboratory University of Chicago United States | 289 | 481 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 3 | 1 |
|
Leukodystrophy and leukoencephalopathy panel. NGS panel of 74 genes. Genologica Medica Spain | 96 | 74 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.